1227606-51-0

Basic information

• Product Name: 2-(Bromomethyl)-4-fluoropyridine
• Synonyms: 2-(Bromomethyl)-4-fluoropyridine;2-(Bromomethyl)-4-fluoropyridineHBr
• CAS NO: 1227606-51-0
• Molecular Formula: C6H5BrFN
• Molecular Weight: 190.0130032
• Mol File: 1227606-51-0.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-(Bromomethyl)-4-fluoropyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(Bromomethyl)-4-fluoropyridine(1227606-51-0)
• EPA Substance Registry System: 2-(Bromomethyl)-4-fluoropyridine(1227606-51-0)

Safety Data

• Hazardous Substances Data: 1227606-51-0(Hazardous Substances Data)

Usage

General Description

2-(Bromomethyl)-4-fluoropyridine is a chemical compound with the molecular formula C6H5BrFN. It is a derivative of pyridine and contains a fluorine atom and a bromomethyl group attached to the pyridine ring. 2-(Bromomethyl)-4-fluoropyridine is commonly used as a building block in organic synthesis and pharmaceutical research, particularly in the development of new drugs. Its properties and reactivity make it a valuable intermediate for the synthesis of various functionalized pyridine derivatives. Additionally, its fluorine and bromine substituents make it a useful tool in studying structure-activity relationships in medicinal chemistry and drug design.

Upstream product

• 766-16-5 para-fluoro-2-methylpyridine 

Relevant articles and documents

Imidazopyrazine compound, and preparation method and application thereof

The invention belongs to the technical field of medicines and relates to an imidazopyrazine compound, and a preparation method and an application thereof. Specifically, the invention relates to a compound with a structure shown in a formula (I) defined in the specification, a pharmaceutically acceptable salt of the compound, a stereisomer of the compound or a prodrug of the compound, and an application of the compound, the pharmaceutically acceptable salt of the compound, the stereisomer of the compound or the prodrug of the compound to the preparation of drugs. The drugs are used for preventing and/or treating diseases and/or symptoms, related to the over-activity of Bruton's tyrosine kinases, of subjects. The invention furthermore relates to an application of the compound, pharmaceutically acceptable salts of the compound, the stereisomer of the compound or the prodrug of the compound to the preparation of preparations. The preparations are used for reducing or inhibiting the activity of the Bruton's tyrosine kinases in cells.